Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds.

AUTOR(ES)

Hazuda, D

RESUMO

In vitro assay systems which use recombinant retroviral integrase (IN) and short DNA oligonucleotides fail to recapitulate the full-site integration reaction as it is known to occur in vivo. The relevance of using such circumscribed in vitro assays to define inhibitors of retroviral integration has not been formerly demonstrated. Therefore, we analyzed a series of structurally diverse inhibitors with respect to inhibition of both half-site and full-site strand transfer reactions with either recombinant or virion-produced IN. Half-site and full-site reactions catalyzed by avian myeloblastosis virus and human immunodeficiency virus type 1 (HIV-1) IN from virions are shown to be equivalently sensitive to inhibition by compounds which inhibit half-site reactions catalyzed by the recombinant HIV-1 IN. These studies therefore support the utility of using in vitro assays employing either recombinant or virion-derived IN to identify inhibitors of integration.

Documentos Relacionados

• Efficiency and Fidelity of Full-Site Integration Reactions Using Recombinant Simian Immunodeficiency Virus Integrase
• Variation of half-site organization and DNA looping by AraC protein.
• Active-site assembly and mode of DNA cleavage by Flp recombinase during full-site recombination.
• DNA bending by thyroid hormone receptor: influence of half-site spacing and RXR.
• Comparison of DNA binding and integration half-site selection by avian myeloblastosis virus integrase.